Per-Patient Dose QA Based On Clinically Relevant Metrics: Validation of the Planned Dose Perturbation Method to Estimate Patient Dose/DVH Using Conventional QA Data
Byline
B Nelms1 *, H Zhen2 , D Savitskij3 , R Hardee3 , W Tome2 , (1) Canis Lupus LLC, Merrimac, WI, (2) University of Wisconsin, Madison, WI, (3) Sun Nuclear Corporation, Melbourne, FL